Skip to content
10-Q

Quarterly Report

BIOXYTRAN, INC. BIXT

0001493152-26-023538

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 15, 2026 114.2M sh
Shares Diluted Q1 2026 · Mar 31, 2026 112.28M sh
Shares Diluted Q1 2026 · Mar 31, 2025 88.84M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$238.61K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$167.32K
Current Liabilities Q1 2026 · Mar 31, 2026 $5.01M
Current Liabilities Q1 2026 · Dec 31, 2025 $3.25M
Total Liabilities Q1 2026 · Mar 31, 2026 $5.01M
Total Liabilities Q1 2026 · Dec 31, 2025 $3.25M
Current Assets Q1 2026 · Mar 31, 2026 $463.05K
Current Assets Q1 2026 · Dec 31, 2025 $513.47K
Total Assets Q1 2026 · Mar 31, 2026 $615.25K
Total Assets Q1 2026 · Dec 31, 2025 $658.55K
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.02
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.02
Eps Basic Q1 2026 · Mar 31, 2026 −$0.02
Eps Basic Q1 2026 · Mar 31, 2025 −$0.02
Rd Expense Q1 2026 · Mar 31, 2026 $225.48K
Rd Expense Q1 2026 · Mar 31, 2025 $349.5K
Net Income Q1 2026 · Mar 31, 2026 −$2.07M
Net Income Q1 2026 · Mar 31, 2025 −$1.35M
Operating Income Q1 2026 · Mar 31, 2026 −$1.93M
Operating Income Q1 2026 · Mar 31, 2025 −$515.14K